Approval · Notice of Compliance 2228 · 2001
COMTAN: Notice of Compliance 2228
Issued May 8, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2228
- Date
- May 8, 2001
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Adjunct to levodopa and ddc inhibitor/comt-inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMTAN | 02243763 | Dormant |
Medicinal ingredients
- ENTACAPONE 200 MG per TAB